Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

JAZZ Stock Forecast, Price Targets, Chart, Dividends & Analysis

Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc

Sector: Healthcare   

Industry: Biotechnology

108.80
 
USD
  
0.93
  
(0.86%)
Previous close: 107.87  Open: 108.18  Bid: 107.3  Ask: 110.0
52 week range    
99.06   
   137.39
Mkt Cap: 6,646 M  Avg Vol (90 Days): 667,566
Peers   
ENDP / 
ABC / 
TEVA / 
Last updated: Sunday 13th October 2024

Stock Rankings

48
MarketXLS Rank
80
Value
23
Technical
42
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABC

179.98

ENDP

0.2926

NVS

TEVA

Financials

JAZZ Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AcquiredInProcessRnDIncome-638000.0
Amortization of intangibles127 M98 M102 M152 M201 M355 M260 M526 M599 M608 M
Basic EPS from continuing operations0.989.224.28-5.52-3.586.55
Basic EPS total0.985.386.568.137.459.224.28-5.52-3.586.55
Basic weighted shares outstanding60 M61 M61 M60 M60 M57 M56 M60 M63 M63 M
Cost of sales122 M-128 M-149 M-441 M-541 M436 M
Depreciation-12 M-13 M-15 M15 M19 M27 M30 M30 M
Depreciation unreconciled127 M98 M102 M152 M201 M355 M260 M526 M599 M608 M
DepreciationAndAmortization127 M98 M102 M152 M201 M355 M260 M526 M599 M608 M
DevelopmentExpense203 M24 M85 M110 M251 M444 M19 M
Diluted EPS total0.935.236.417.967.39.094.22-5.52-3.586.1
Diluted normalized net income/share0.939.094.22-5.52-3.586.1
Diluted weighted shares outstanding63 M63 M62 M61 M61 M58 M57 M60 M63 M72 M
Earnings from equity interest-379000.0-1 M-4 M-4 M-3 M-714000.0-10 M-3 M
EarningsFromEquityInterestNetOfTax-379000.0-1 M-4 M-4 M-3 M-714000.0-10 M-3 M
GainOnSaleOfBusiness-638000.0100000.0-1 M
GainOnSaleOfPPE-473000.0-655000.0-21000.0
GainOnSaleOfSecurity-17 M
GeneralAndAdministrativeExpense-11 M-10 M-12 M-15 M-12 M737 M854 M1,452 M1,417 M1,343 M
Gross operating profit1,173 M1,325 M1,488 M1,619 M1,769 M2,290 M2,215 M2,653 M3,119 M3,399 M
ImpairmentOfCapitalAssets39 M32 M43 M136 M134 M
Income before tax152 M436 M532 M441 M529 M454 M275 M-113 M-373 M298 M
Income restructuring and M&A-2 M-2 M
Income taxes94 M106 M135 M-48 M80 M-73 M34 M216 M-159 M-120 M
Interest income-53 M-57 M-62 M-78 M-77 M-72 M-100 M-279 M-288 M-289 M
InterestExpenseNonOperating-27 M-38 M-57 M59 M100 M279 M288 M289 M
MinorityInterests1 M1000.0
MiscOtherSpecialCharges9 M1 M7 M5 M5 M3 M2 M
Net income from total operations58 M330 M397 M488 M447 M523 M239 M-330 M-224 M415 M
NetIncomeCommonStockholders58 M330 M397 M488 M447 M779 M239 M-330 M-224 M415 M
NetIncomeContinuousOperations58 M330 M397 M488 M447 M523 M239 M-330 M-224 M415 M
NetNonOperatingInterestIncomeExpense-53 M-57 M-62 M-78 M-77 M-72 M-100 M-279 M-288 M-289 M
Operating income235 M540 M592 M529 M658 M532 M378 M170 M-66 M579 M
Operating income before depreciation (EBITDA)299 M567 M641 M598 M733 M930 M653 M718 M545 M1,226 M
OperatingExpense-977 M-817 M-896 M-1,090 M1,112 M1,501 M1,700 M2,483 M3,051 M2,801 M
Other income net-9 M17 M1 M1 M4 M4 M3 M714000.010 M-10 M
OtherGandA-11 M-10 M-12 M-15 M-12 M737 M854 M1,452 M1,417 M1,343 M
OtherOperatingExpenses117 M103 M105 M110 M-23 M-28 M-28 M-27 M-25 M-15 M
PromotionAndAdvertising-1000000.0-28 M-29 M-37 M-37 M65 M100 M162 M109 M92 M
RentAndLandingFees-11 M-10 M-12 M-15 M-12 M
Research & development expense288 M135 M186 M283 M227 M410 M587 M506 M1,035 M869 M
ResearchExpense85 M135 M162 M198 M227 M300 M335 M506 M590 M850 M
RestructringAndMnAIncome-2 M-2 M
Revenue per share127 M98 M102 M152 M201 M355 M260 M526 M599 M608 M
SalariesAndWages-70 M-92 M-99 M-107 M-102 M-16 M-13 M-34 M-41 M-40 M
Selling Gen & administrative expense406 M449 M503 M544 M684 M737 M854 M1,452 M1,417 M1,343 M
SellingAndMarketingExpense406 M449 M503 M544 M684 M65 M100 M162 M109 M92 M
SellingExpense406 M449 M503 M544 M684 M
Special income/charges-39 M-32 M-43 M-136 M-134 M
Total Income available for interest expense (EBIT)152 M436 M505 M403 M473 M513 M375 M166 M-85 M587 M
Total common shares outstanding61 M61 M60 M60 M57 M56 M56 M62 M63 M62 M
Total net income58 M330 M397 M488 M447 M523 M239 M-330 M-224 M415 M
Total ordinary shares62 M62 M62 M62 M62 M62 M62 M62 M62 M62 M
Total revenues1,173 M1,325 M1,488 M1,619 M1,891 M2,162 M2,364 M3,094 M3,659 M3,834 M
TotalExpenses-977 M-817 M-896 M-1,090 M1,233 M1,374 M1,552 M2,042 M2,510 M3,237 M
TotalRevenue1,163 M1,317 M1,477 M1,619 M1,891 M2,162 M2,364 M3,094 M3,659 M3,834 M
WriteDown-13 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University